Answers are grounded in this paper and cite their sources.
Glycemic states evolve dynamically from normoglycemia to prediabetes and type 2 diabetes mellitus (T2DM), with changing risks of subsequent cardiovascular disease (CVD). Understanding these cardiometabolic trajectories earlier in adulthood is increasingly important as the burden of dysglycemia extends to younger populations. However, evidence remains limited regarding how repeatedly measured clinical and biochemical markers are differentially associated with specific transitions across the cardiometabolic disease course. We aimed to characterize longitudinal transition patterns and transition-specific associations using a multistate model in a relatively young Korean cohort. This retrospective cohort study included 134,575 participants (median age, 39 years; median follow-up, 8.95 years) from Kangbuk Samsung Health Study. Participants without T2DM and CVD at baseline (2012–2013) were followed through repeated health examinations until December 2024. A four-state multistate model was used to estimate 5- and 10-year transition probabilities across normoglycemia, prediabetes, T2DM, and CVD. Factors associated with each of seven transitions were evaluated using transition-specific Cox proportional hazards models, with covariates measured at entry into each origin state. During follow-up, transitions between normoglycemia and prediabetes were frequent. Among participants starting in prediabetes, the 10-year probability of reversion to normoglycemia was 47.26% (95% CI, 46.81–47.70), whereas the probabilities of progression to T2DM and CVD were 7.70% (95% CI, 7.51–7.90) and 2.70% (95% CI, 2.58–2.82), respectively. Among those starting in normoglycemia, the corresponding 10-year probabilities of occupying T2DM and CVD were 5.22% (95% CI, 5.07–5.37) and 2.32% (95% CI, 2.21–2.42). Transition-specific associations were heterogeneous: age and hypertension showed relatively broad associations across glycemic and CVD-related transitions, whereas triglyceride levels, HOMA-IR, and other metabolic and body-composition measures showed more transition-specific patterns. Cardiometabolic trajectories were characterized by dynamic transitions across normoglycemia, prediabetes, T2DM, and CVD, with associated factors differing across transitions. Prediabetes was a particularly dynamic state in which both progression and reversion were common. These findings highlight the importance of considering an individual’s current glycemic and cardiometabolic state when evaluating subsequent disease trajectories.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: